GLYCOLIPIDS AS THE MAJOR AUTOANTIGENS OF CYTOPLASMATIC ISLET-CELL ANTIBODIES

被引：6

作者：

CABRERARODE, E

DIAZHORTA, O

FERNANDEZ, LE

CARR, A

MARQUINA, G

VALIENTE, O

GONZALEZSUAREZ, RM

URIARTE, A

机构：

[1] National Institute of Endocrinology, Havana

[2] Center of Molecular Immunology, Havana

来源：

AUTOIMMUNITY | 1995年 / 20卷 / 03期

关键词：

ISLET CELL ANTIBODIES; GANGLIOSIDES; GLYCOLIPIDS; INSULIN-DEPENDENT DIABETES; AUTOANTIGEN;

D O I：

10.3109/08916939508993345

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

It has been recently suggested that pancreatic glycolipidic extracts and acidic glycolipid fractions are able to block the binding of ICA to frozen sections of human pancreas. We study the prevalence of blocking effect by the upper-phase from human pancreatic glycolipid extracts (PGE) in thirty-eight sera ICA positive from seventeen IDDM patients and twenty-one first relatives of type 1 diabetics. Total inhibition was found in 82% and 76% insulin dependent diabetes mellitus patients and first relatives of type 1 diabetics respectively. Partial and no inhibition of ICA + sera was seen in 6%, 12% of type 1 diabetics and 19%, 5% of the first degree relatives of type 1 diabetics respectively. Our study suggests that there is heterogeneity of cytoplasmatic islet cell antibodies and that glycolipids are the major autoantigen of ICA.

引用

页码：145 / 151

页数：7

共 29 条

[1]

Andreani D., Di Mario U., Pozzilli P., Prediction, Prevention, and Early Intervention in Insulin-Dependent Diabetes, Diabetes/Metabolism Reviews, 7, pp. 61-67, (1991)

[2]

Bottazzo G.F., Florin-Christensen A., Doniach D., Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies, Lancet, 2, pp. 1279-1283, (1974)

[3]

McCuish A.C., Barnes E.W., Irvine W.J., Duncan J.P., Antibodies in Pancreatic islet cells in insulin-dependent diabetes with coexistent autoimmune disease, Lancet, 2, pp. 1529-1532, (1974)

[4]

Colman P.G., Nayak R.C., Campbell A.L., Eisenbarth G.S., Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts, Diabetes, 37, pp. 645-652, (1985)

[5]

Nayak R.S., Omar M.A.K., Rabizadeh A., Srikanta S., Eisenbarth G.S., Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate, Diabetes, 34, pp. 617-619, (1985)

[6]

Portoukalian J., Rebbaa A., Thivolet C., Detection on thin layer plates of antibodies to human pancreatic gangliossides in the sera of type 1 diabetes patients, Diabetes, 39

[7]

Previti M., Tiberti C., Dotta F., Lenti L., Pontieri G.M., Andreani D., Di Mario U., Ganglioside characterization of human and rat pancreas: their role in endocrine auto-4immunity, J. Endocrinol. Invest, 13, (1990)

[8]

Portoukalian J., Rebbaa A., Thivolet C.H., Detection on thin layer plates of autoantibodies to human pancreatic fucogangliosides in the sera of ICA positive type 1 diabetic patients, Diabetologia., 33, (1990)

[9]

Cabrera E., Fernandez L.E., Carr A., Marquina G., Valiente O., Uriarte A., Rynmark B.M., Fredman P., Svennerholm L., Which glycolipids are the autoantigens of cytoplasmatic islet cell antibodies?, Acta Diabetologica., 29, pp. 70-74, (1992)

[10]

Harrison L.C., Multiple islet antigens in IDDM: order out of chaos?, International diabetes monitor, 4, pp. 1-6, (1992)

← 1 2 3 →